How much does Adempas (Riociguat Tablets) Cost& price without insurance in China?
Adempas® is the commercial brand name of Riociguat Tablets, an orally active soluble guanylate cyclase stimulator developed by Bayer. It stimulates soluble guanylate cyclase to elevate intracellular cGMP concentration, dilate pulmonary vasculature and reduce pulmonary arterial pressure.
Main Indications
Treatment of adult patients with pulmonary arterial hypertension (PAH, WHO functional class II–III) to improve exercise capacity;
Treatment of chronic thromboembolic pulmonary hypertension (CTEPH) after surgical intervention or for inoperable cases to boost patients’ exercise tolerance.
Common Side Effects
Common mild adverse reactions: Headache, facial flushing, dizziness, dyspepsia and peripheral edema.
Laboratory abnormalities: Rare mild hemoglobin reduction.
Severe but manageable risks: Severe symptomatic hypotension, gastrointestinal hemorrhage and hypersensitivity reactions.
Approval Status in China
Adempas® (Riociguat Tablets, 1mg, domestic Chinese brand name: Anji’ao) was officially approved for marketing in China in 2017. It is currently a prescription drug included in China’s Category B medical insurance.
Buy Adempas (Riociguat Tablets) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
